NEW YORK – QuidelOrtho announced Monday an integration deal making fecal biomarker testing from Bühlmann Laboratories available on QuidelOrtho's Vitros system. The Bühlmann fecal tests detect ...

The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.

Research published in the scientific journal The Lancet found that fecal immunochemical testing (FIT) was comparable to ...

Gut Zoomer provides insights crucial in identifying the root causes of chronic disease and other conditions that impact ...

To support this advocacy, the PhilHealth Public Affairs Unit, led by Kenneth M. Po, assisted the regional information officers in the on-site registration for the Konsulta Program during the ...

According to new survey data commissioned by the Colorectal Cancer Alliance more than half of U.S. adults would rather do ...

Guaiac-based Fecal Occult Blood Test (gFOBT) Like FIT, gFOBT is an at-home, stool-based screening test for colon cancer. It requires you to collect samples from three bowel movements, rather than only ...

Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim: To ...

A groundbreaking blood test for colorectal cancer screening could reshape early detection. Learn how this FDA-approved method offers new hope.

The researchers analyzed the 2018-2020 EHIS data to assess the use of a fecal test [fecal immunochemical test (FIT) or guaiac-based fecal occult blood test (gFOBT)] in the previous two years or a ...